Diagnostic criteria for apathy in neurocognitive disorders

被引:90
|
作者
Miller, David S. [1 ]
Robert, Philippe [2 ,3 ,4 ]
Ereshefsky, Larry [5 ]
Adler, Lawrence [6 ]
Bateman, Daniel [7 ]
Cummings, Jeff [8 ,9 ]
DeKosky, Steven T. [10 ]
Fischer, Corinne E. [11 ,12 ]
Husain, Masud [13 ,14 ,15 ]
Ismail, Zahinoor [16 ]
Jaeger, Judith [17 ]
Lerner, Alan J. [18 ]
Li, Abby [19 ]
Lyketsos, Constantine G. [20 ]
Manera, Valeria [2 ,3 ]
Mintzer, Jacobo [21 ,22 ]
Moebius, Hans J. [23 ]
Mortby, Moyra [24 ]
Meulien, Didier [25 ]
Pollentier, Stephane [26 ]
Porsteinsson, Anton [27 ]
Rasmussen, Jill [28 ]
Rosenberg, Paul B. [20 ]
Ruthirakuhan, Myuri T. [19 ]
Sano, Mary [29 ]
Sarracini, Carla Zucchero [19 ]
Lanctot, Krista L. [19 ,30 ,31 ]
机构
[1] Signant Health, Blue Bell, PA USA
[2] Univ Cote dAzur, Cognit Behav Technol Lab, Nice, France
[3] Assoc Innovat Alzheimer, Nice, France
[4] Univ Nice, Ctr Memoire, Ctr Hosp, Nice, France
[5] Follow Mol, Marina Del Rey, CA USA
[6] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA
[7] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
[8] Univ Nevada, Sch Integrated Hlth Sci, Dept Brain Hlth, Las Vegas, NV USA
[9] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA
[10] Univ Florida, Dept Neurol, McKnight Brain Inst, Gainesville, FL USA
[11] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[12] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Res, Toronto, ON, Canada
[13] Univ Oxford, Dept Expt Psychol, Oxford, England
[14] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England
[15] Oxford NIHR Biomed Res Ctr, Oxford, England
[16] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[17] CognitionMetrics, Wilmington, DE USA
[18] Case Western Reserve Univ, Univ Hosp, Cleveland, OH USA
[19] Sunnybrook Res Inst, Toronto, ON, Canada
[20] Johns Hopkins Univ, Baltimore, MD USA
[21] Med Univ South Carolina, Charleston, SC 29425 USA
[22] Ralph H Johnson Vet Adm Med Ctr, Charleston, SC USA
[23] Moebius Consult, Baar, Switzerland
[24] Univ New South Wales, UNSW Ageing Futures Inst, Sydney, NSW, Australia
[25] H Lundbeck & Co AS, Clin Res & Dev, Valby, Denmark
[26] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany
[27] Univ Rochester, Rochester, NY USA
[28] Psi Napse, Dorking, Surrey, England
[29] Icahn Sch Med Mt Sinai, Dept Psychiat, Alzheimer Dis Res Ctr, New York, NY USA
[30] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[31] Univ Toronto, Dept Pharmacol Toxicol, Toronto, ON, Canada
关键词
apathy; behavior; cognition; diagnostic criteria; emotion; motivation; neurocognitive disorder (NCD); neuropsychiatric symptoms (NPS); MILD COGNITIVE IMPAIRMENT; NURSING-HOME RESIDENTS; DISEASE RATING-SCALE; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; PARKINSONS-DISEASE; FRONTOTEMPORAL DEMENTIA; NONPHARMACOLOGICAL TREATMENT; PSYCHOMETRIC PROPERTIES; AMYLOID BURDEN;
D O I
10.1002/alz.12358
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction Apathy is common in neurocognitive disorders (NCD) but NCD-specific diagnostic criteria are needed. Methods The International Society for CNS Clinical Trials Methodology Apathy Work Group convened an expert group and sought input from academia, health-care, industry, and regulatory bodies. A modified Delphi methodology was followed, and included an extensive literature review, two surveys, and two meetings at international conferences, culminating in a consensus meeting in 2019. Results The final criteria reached consensus with more than 80% agreement on all parts and included: limited to people with NCD; symptoms persistent or frequently recurrent over at least 4 weeks, a change from the patient's usual behavior, and including one of the following: diminished initiative, diminished interest, or diminished emotional expression/responsiveness; causing significant functional impairment and not exclusively explained by other etiologies. Discussion These criteria provide a framework for defining apathy as a unique clinical construct in NCD for diagnosis and further research.
引用
收藏
页码:1892 / 1904
页数:13
相关论文
共 50 条
  • [41] Apathy in Parkinson's disease: Diagnostic and etiological dilemmas
    Starkstein, Sergio E.
    MOVEMENT DISORDERS, 2012, 27 (02) : 174 - 178
  • [42] Poststroke apathy: Major role of cognitive, depressive and neurological disorders over imaging determinants
    Aubignat, Mickael
    Roussel, Martine
    Aarabi, Ardalan
    Lamy, Chantal
    Andriuta, Daniela
    Tasseel-Ponche, Sophie
    Makki, Malek
    Godefroy, Olivier
    CORTEX, 2023, 160 : 55 - 66
  • [43] Neurocognitive disorders in Parkinson's disease
    Tivadar, Lucza
    Kazmer, Karadi
    Samuel, Komoly
    Jozsef, Janszky
    Janos, Kallai
    Attila, Makkos
    Marton, Kovacs
    Rita, Weintraut
    Gabriella, Deli
    Zsuzsanna, Aschermann
    Norbert, Kovacs
    ORVOSI HETILAP, 2015, 156 (23) : 915 - 926
  • [44] Diagnostic Criteria For Pediatric Mitochondrial Disorders
    Karimzadeh, Parvaneh
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2013, 7 (04) : 8 - 8
  • [45] Apathy and neurocognitive correlates: review from the perspective of 'precision psychiatry'
    Gracia-Garcia, Patricia
    Modrego, Pedro
    Lobo, Antonio
    CURRENT OPINION IN PSYCHIATRY, 2021, 34 (02) : 193 - 198
  • [46] Treatment of Apathy in Huntington's Disease and Other Movement Disorders
    Krishnamoorthy, Ashok
    Craufurd, David
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2011, 13 (05) : 508 - 519
  • [47] Pharmacological treatment of apathy in Lewy body disorders: A systematic review
    Liu, Jennifer
    Cooper, Christine A.
    Weintraub, Daniel
    Dahodwala, Nabila
    PARKINSONISM & RELATED DISORDERS, 2019, 60 : 14 - 24
  • [48] Cutoff scores for the "Interest game", an application for the assessment of diminished interest in neurocognitive disorders
    Manera, Valeria
    Fabre, Roxane
    Daumas, Lyne
    Zeghari, Radia
    Derreumaux, Alexandre
    Payne, Magali
    Lemaire, Justine
    Sacco, Guillaume
    Gros, Auriane
    Robert, Philippe
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [49] Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders
    Cabreira, Veronica
    Alty, Jane
    Antic, Sonja
    Araujo, Rui
    Aybek, Selma
    Ball, Harriet A.
    Baslet, Gaston
    Bhome, Rohan
    Coebergh, Jan
    Dubois, Bruno
    Edwards, Mark
    Filipovic, Sasa R.
    Frederiksen, Kristian Steen
    Harbo, Thomas
    Hayhow, Bradleigh
    Howard, Robert
    Huntley, Jonathan
    Isaacs, Jeremy Darryl
    Lafrance, Curt
    Larner, Andrew
    Di Lorenzo, Francesco
    Main, James
    Mallam, Elizabeth
    Marra, Camillo
    Massano, Joao
    Mcgrath, Emer R.
    Portela Moreira, Isabel
    Nobili, Flavio
    Pal, Suvankar
    Pennington, Catherine M.
    Tabuas-Pereira, Miguel
    Perez, David
    Popkirov, Stoyan
    Rayment, Dane
    Rossor, Martin
    Russo, Mirella
    Santana, Isabel
    Schott, Jonathan
    Scott, Emmi P.
    Taipa, Ricardo
    Teodoro, Tiago
    Tinazzi, Michele
    Tomic, Svetlana
    Toniolo, Sofia
    Torring, Caroline Winther
    Wilkinson, Tim
    Zeidler, Martin
    Frostholm, Lisbeth
    Mcwhirter, Laura
    Stone, Jon
    BMJ NEUROLOGY OPEN, 2025, 7 (01)
  • [50] A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes
    Bellomo, G.
    Piscopo, P.
    Corbo, M.
    Pupillo, E.
    Stipa, G.
    Beghi, E.
    Vanacore, N.
    Lacorte, E.
    NEUROLOGICAL SCIENCES, 2022, 43 (12) : 6667 - 6691